about
Population pharmacokinetics of deferiprone in healthy subjects.Effects of Vitamin E and Zinc Supplementation on Antioxidants in Beta thalassemia major PatientsDeferiprone in the treatment of transfusion-dependent thalassemia: a review and perspectiveImproved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonanceBrazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion.Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone.Functional analyses of recombinant mouse hepcidin-1 in cell culture and animal model.Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease.Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone).Synthesis of polymers containing 3-hydroxypyridin-4-one bidentate ligands for treatment of iron overload.Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.Deferiprone (GPO-L-ONE(®) ) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand.
P2860
Q34635568-78E7C6E4-8EFA-4D34-BAB4-B56EF3A16B61Q36244677-20621E76-D14B-4F81-A347-1AA6FF7C2F2DQ36645815-EED656B8-AA86-498C-9BC2-B1762C7093AFQ36926651-8F88937A-D440-4EFF-B1BE-F98D2C1A7C0EQ37528626-1905B7C4-E37F-4612-BD2C-EE5D2E95C47AQ37762809-8A906405-D975-4267-A71A-3FD1B613C62BQ39171979-D43610C9-8EBF-4EE3-B7B2-B56F7C250D25Q39377048-4D119027-B09B-43AB-9473-7BE4CA78F796Q39552627-164D357E-5B8B-444D-B3BB-635857A3E49FQ40901148-7E3B5219-E832-444A-860B-D856CBEFA1AFQ43199005-B82AFA56-0D15-4F5A-93FC-70F5DE8ED69DQ43667169-23648DDE-E1C0-4EC7-AA6A-62900A780D7CQ53995645-07B7E429-2063-429E-8A48-772BFBC4B86A
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Deferiprone therapy for transfusional iron overload
@ast
Deferiprone therapy for transfusional iron overload
@en
Deferiprone therapy for transfusional iron overload
@nl
type
label
Deferiprone therapy for transfusional iron overload
@ast
Deferiprone therapy for transfusional iron overload
@en
Deferiprone therapy for transfusional iron overload
@nl
prefLabel
Deferiprone therapy for transfusional iron overload
@ast
Deferiprone therapy for transfusional iron overload
@en
Deferiprone therapy for transfusional iron overload
@nl
P1476
Deferiprone therapy for transfusional iron overload
@en
P2093
A Victor Hoffbrand
P304
P356
10.1016/J.BEHA.2004.08.026
P407
P577
2005-06-01T00:00:00Z